Digital Future

Why a data and privacy strategy empowers genomics

As we stand on the brink of the personalized medicine era, breakthroughs in areas like genomics are opening up a whole new range of privacy, reliability and security issues. Embedding security and privacy within strategy empowers Life Sciences companies.

New privacy challenges: easier access to cross-border electronic evidence

According to the EU Commission, electronic evidence is needed in around 85% of criminal investigations. In two-thirds of these investigations, evidence must be obtained from online service providers in other jurisdictions.
1

New EU MDR 2020 regulations: are your apps ready?

The transition phase for the implementation of the EU-MDR ends in May 2020. The pressure is great to make physical medical devices, business processes as well as existing and future mobile medical applications compliant or even to certify them.

From predictive to prescriptive analytics

Companies still struggle to make better, data-driven decisions, despite more powerful (big) data infrastructures and the availability of sophisticated predictive analytics, AI and machine learning methodologies.
4

How Intelligent Automation impacts employees

As Intelligent Automation (IA) changes businesses processes and operating models, humans will be working and making decisions alongside robots and algorithms. What impact will this shift have on employees in a world of digital-first organizations?
1

Genomics – a blueprint for successful outcomes?

This month marks the 16th anniversary of the first full publication of the human genome. Far from being old news, the potential of genomics continues to grow. In what’s already a period of transformation for Life Sciences companies, how can they drive value from genomics, and what are the pitfalls to be avoided?
3 1